Literature DB >> 20234884

Analysis of recombinant Duffy protein-linked N-glycans using lectins and glycosidases.

Magdalena Grodecka1, Marcin Czerwiński, Maria Duk, Elwira Lisowska, Kazimiera Waśniowska.   

Abstract

Duffy antigen is a glycosylated blood group protein acting as a malarial and chemokine receptor. Using glycosylation mutants we have previously demonstrated, that all three potential glycosylation sites of the Duffy antigen are occupied by N-linked oligosaccharide chains. In this study, wild-type Duffy glycoprotein and three mutants, each containing a single N-glycan, were used to characterize the oligosaccharide chains by lectin blotting and endoglycosidase digestion. The positive reaction of all the recombinant Duffy forms with Datura stramonium and Sambucus nigra lectins showed that each Duffy N-linked glycan contains Galbeta1-4GlcNAc units terminated by (alpha2-6)-linked sialic acid residues, typical of complex oligosaccharides. The reactivity with Aleuria aurantia and Lens culinaris lectins suggested the presence of (alpha1-6)-linked fucose at the N-glycan chitobiose core. The failure of the Galanthus nivalis and Canavalia ensiformis lectins to bind to any of the Duffy mutants or to the wild-type antigen indicated that none of the three Duffy N-glycosylation sites carries detectable levels of high-mannose oligosaccharide chains. Digestion of Duffy samples with peptide N-glycosidase F and endoglycosidase H confirmed the presence of N-linked complex oligosaccharides. Our results indicate that Duffy antigen N-glycans are mostly core-fucosylated complex type oligosaccharides rich in N-acetyllactosamine and terminated by (alpha2-6)-linked sialic acid residues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20234884

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  4 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  One-step immunopurification and lectinochemical characterization of the Duffy atypical chemokine receptor from human erythrocytes.

Authors:  Magdalena Grodecka; Olivier Bertrand; Ewa Karolak; Marek Lisowski; Kazimiera Waśniowska
Journal:  Glycoconj J       Date:  2012-01-14       Impact factor: 2.916

3.  Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity.

Authors:  Dorota Smolarek; Claude Hattab; Anna Buczkowska; Radoslaw Kaczmarek; Anna Jarząb; Sylvie Cochet; Alexandre G de Brevern; Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Magdalena Grodecka; Kazimiera Wasniowska; Yves Colin Aronovicz; Olivier Bertrand; Marcin Czerwinski
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 4.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.